Organigram Global (OGI) Change in Cash (2018 - 2026)
Organigram Global (OGI) posted quarterly Change in Cash of $45.3 billion for Q1 2026, down 5.3% year-on-year from $47.9 billion in Q1 2025, and up 75517.36% on a QoQ basis from $59.9 million in Q4 2025.
Organigram Global (OGI) Change in Cash (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Change in Cash for 7 consecutive years, with $45.3 billion the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash fell 5.3% year-over-year to $45.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.4 billion (down 38.54% YoY) and the FY2025 annual result came in at -$35.6 million, down 160.09% from the prior year.
- Change in Cash climbed to $45.3 billion in Q1 2026 per OGI's latest filing, from $59.9 million in the prior quarter.
- Over the last five years, Change in Cash for OGI reached as high as $47.9 billion in Q1 2025 and fell as low as $59.9 million in Q4 2025.
- A 3-year average of $23.3 billion and a median of $22.7 billion in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash plunged 36.85% — and 2026, when it declined 5.3%.
- Year by year, Change in Cash stood at $94.9 million in 2024, then tumbled by 36.85% to $59.9 million in 2025, then surged by 75517.36% to $45.3 billion in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $45.3 billion, $59.9 million, and $47.9 billion for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 45.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.33 Bn |
| Dec 31, 2025 | 59.94 Mn |
| Mar 31, 2025 | 47.87 Bn |
| Dec 31, 2024 | 94.93 Mn |
| May 31, 2021 | 33.79 Mn |
| Feb 28, 2021 | 103.90 Bn |
| Nov 30, 2020 | 24.60 Bn |
| Aug 31, 2020 | -52.47 Mn |
| May 31, 2020 | 29.38 Mn |
| Feb 29, 2020 | -7.13 Mn |
| Aug 31, 2019 | 47,190.00 |
| May 31, 2019 | 9.32 Mn |
| Feb 28, 2019 | 17.69 Mn |
| Nov 30, 2018 | 24.90 Mn |